IRONWOOD PHARMACEUTICALS, INC. (IRWD) Shareholders’ equity 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) shareholders’ equity at each fiscal year-end, per SEC filings.
-$261.8MFY2025 · since FY2016: $66.7M → -$261.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$261.8M | +13.1% |
| FY2024 | -$301.3M | +13.0% |
| FY2023 | -$346.3M | -153.1% |
| FY2022 | $652.4M | +7.7% |
| FY2021 | $605.9M | +867.3% |
| FY2020 | $62.6M | +167.2% |
| FY2019 | -$93.3M | +52.5% |
| FY2018 | -$196.4M | -2094.0% |
| FY2017 | $9.8M | -85.2% |
| FY2016 | $66.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice